GB2160870A - Process for preparing peptides - Google Patents
Process for preparing peptides Download PDFInfo
- Publication number
- GB2160870A GB2160870A GB08516281A GB8516281A GB2160870A GB 2160870 A GB2160870 A GB 2160870A GB 08516281 A GB08516281 A GB 08516281A GB 8516281 A GB8516281 A GB 8516281A GB 2160870 A GB2160870 A GB 2160870A
- Authority
- GB
- United Kingdom
- Prior art keywords
- process according
- enzyme
- carried out
- enzymatic hydrolysis
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- 108090000765 processed proteins & peptides Proteins 0.000 title description 4
- 102000004196 processed proteins & peptides Human genes 0.000 title description 3
- 238000000034 method Methods 0.000 claims description 35
- 108090000790 Enzymes Proteins 0.000 claims description 32
- 102000004190 Enzymes Human genes 0.000 claims description 32
- 230000008569 process Effects 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 23
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 8
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 230000002111 hydrolasic effect Effects 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 4
- 241000187654 Nocardia Species 0.000 claims description 4
- 241000588769 Proteus <enterobacteria> Species 0.000 claims description 4
- 241000187747 Streptomyces Species 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 241001619326 Cephalosporium Species 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 241000228143 Penicillium Species 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 241000590020 Achromobacter Species 0.000 claims description 2
- 241000187844 Actinoplanes Species 0.000 claims description 2
- 241000588986 Alcaligenes Species 0.000 claims description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 241000588807 Bordetella Species 0.000 claims description 2
- 241001465180 Botrytis Species 0.000 claims description 2
- 241000186321 Cellulomonas Species 0.000 claims description 2
- 241000186216 Corynebacterium Species 0.000 claims description 2
- 241000190562 Emericellopsis Species 0.000 claims description 2
- 241001492222 Epicoccum Species 0.000 claims description 2
- 241001480035 Epidermophyton Species 0.000 claims description 2
- 241000588698 Erwinia Species 0.000 claims description 2
- 241000589565 Flavobacterium Species 0.000 claims description 2
- 241000192041 Micrococcus Species 0.000 claims description 2
- 241000235395 Mucor Species 0.000 claims description 2
- 241001503951 Phoma Species 0.000 claims description 2
- 241000607142 Salmonella Species 0.000 claims description 2
- 241000192023 Sarcina Species 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 2
- 241001446247 uncultured actinomycete Species 0.000 claims 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 claims 1
- 241000223218 Fusarium Species 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000605 aspartame Substances 0.000 description 8
- 229960003438 aspartame Drugs 0.000 description 8
- 235000010357 aspartame Nutrition 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 150000004702 methyl esters Chemical class 0.000 description 8
- 108010011485 Aspartame Proteins 0.000 description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 7
- 235000010633 broth Nutrition 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 108010093096 Immobilized Enzymes Proteins 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 230000007073 chemical hydrolysis Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229960000587 glutaral Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- MNTNRMNWUQSFOI-VIFPVBQESA-N n-[(3s)-2,5-dioxooxolan-3-yl]-2-phenylacetamide Chemical compound N([C@@H]1C(OC(=O)C1)=O)C(=O)CC1=CC=CC=C1 MNTNRMNWUQSFOI-VIFPVBQESA-N 0.000 description 2
- 229960003424 phenylacetic acid Drugs 0.000 description 2
- 239000003279 phenylacetic acid Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- BFCZKXYIMLCSMJ-UHFFFAOYSA-N 2-(4-hydroxyphenyl)acetyl chloride Chemical compound OC1=CC=C(CC(Cl)=O)C=C1 BFCZKXYIMLCSMJ-UHFFFAOYSA-N 0.000 description 1
- PKUPAJQAJXVUEK-UHFFFAOYSA-N 2-phenoxyacetyl chloride Chemical compound ClC(=O)COC1=CC=CC=C1 PKUPAJQAJXVUEK-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000187840 Actinoplanes utahensis Species 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- SVFKZPQPMMZHLZ-UHFFFAOYSA-N N-Phenylacetylaspartic acid Chemical compound OC(=O)CC(C(O)=O)NC(=O)CC1=CC=CC=C1 SVFKZPQPMMZHLZ-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002993 phenylalanine derivatives Chemical class 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
- C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
- C07K5/0613—Aspartame
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Seasonings (AREA)
Description
1 GB 2 160 870 A 1
SPECIFICATION
Process for preparing peptides The invention relates to a process for the preparation of peptides and more particularly to a process for the preparation of lower alkyl esters of L-cx-aspartyl-L-phenylaianine by enzymatic hydrolysis of suitable N- acyl-derivatives The lower alkyl esters of L-a-aspartyl- L-phenylalanine include the methyl ester, which is the well known sweetening agent aspartame.
In the specific field of the preparation of aspartame, an N-acyl- L-(xaspartyl-L-phenylalanine methyl prepared from an acyl-L-aspartyl derivative and L-phenylalanine methyl ester, is usually hydrolyzed chemically, for example by a strong acid (US 4071511) or by a base such as hydroxylamine or acety1hydrazine (GB 2098220). However, the process of chemical hydrolysis has several disadvantages. Principally, it is aspecific and leads to the formation of by-products. Peptido hydrolasic reactions form aspartic acid and phenylalanine derivatives. Esterasic reactions form demethylated aspartames. Cyclization reac- tions form variously substituted diketopiperazines. The presence of all these by-products, besides lowering the production yields, makes it difficult to extract the desired compound at the desired degree o purity. Further chemical and biochemical processes are also needed to recover the important by-products of the reaction so as to optimize the process from an economic point of view.
The invention provides a process for the preparation of an ester of L-(xaspartyl-L-phenylaianine having 20 the general formula I COOR, 1 H2N-CH-uU-NH-uti-uH2-C,H, 1 UM2-CO01-1 (1) wherein R, represents an alkyl group having from 1 to 4 carbon atoms, the process comprising enzymatically hydrolysing an N-acyl derivative of the desired product, which N-acyl derivative has the general 30 formula 11 3E COOR, 1 R-CO-N H-CH-CO-N H-CM-t;'12-1-;J15 i (;H,-uuutl (11) wherein R represents a free or substituted alkyl, alkenyl or phenylalkyl group having from 1 to 11 carbon atoms and R, is as above defined. 40 Preferably R, represents a methyl group and R represents a hydrogen atom or a group of the formula 40 CH,, -(CH,)nCH3wherein n is a number of from 1 to 10, -C,H,, -CH,-CH,, -CH2-C,,H,- OH, -CH2-C,H,-NO,, C,H3(OCH3)2, -CH2-C,H,(OH) 21 -CH2-CH=CH-CH2-CH,-CH2-S-CH2-CH=CH, or CH2-0-R' wherein R' represents a phenyl, hydroxyphenyl or tolyl group or a straight chain alkyl group having from 1 to 6 carbon atoms. The process of the invention, using enzymatic hydrolysis, allows the final product to be obtained, un- der conditions remarkably plainer than those used in the chemical hydrolysis, in very high yields and with a drastic reduction of the quantity of undesired by-products. Hydrolasic enzymes suitable for the present process are, for example, acid or neutral proteasis which under appropriate conditions hydrolyze the amidic bond of an N-acyl-peptide with the formation of the desired peptide.
Particularly, preferred hydrolasic enzymes for the process of enzymatic hydrolysis of N-acyl-aspartame are deacylating enzymes obtained from microbic strains of Escherichia, Nocardia, Proteus, Penicillium, 50 Aspergillus or Streptomyces genus, commonly classified as acylasis and more specifically as Penicillin acylasis.
The hydrolytic process can be carried out either by using directly the free or immobilized microbic cells or by isolating the specific enzymes which c9n be used in the free form, immobilized according to known techniques to resins, glass, cellulose or similar substances by ionic or covalent bonds or grafted to fibres 55 permeable to the substrate, or insolubilized by cross-linkage. Immobilization or insolubilization is advan tageous as the same enzyme can be used for many production cycles. The use of the enzymes isolated and purified to the desired degree is preferred rather than the raw cellular extract since the extraction or purification process normally allows a reduction or elimination of the presence of contaminated enzymes which could lower the yields by formation of undesired by-products.
Some examples of suitable enzymes are those of fungal origin acylasis producted by fermentation of various species of actinomycetes, filamentous fungi and yeasts, such as 2 GB 2 160 870 A 2 Aiternatia Mucor Aspergillus Penicillium Botrytis Phoma Cephalosporium Streptomyces Cryptococcus Trichoderma Emericellopsis Trichophyton Epicoccum Trichosporon Epidermophyton Actinoplanes Fasarium Nocardia 10 or those of bacterial origin acylasis produced by fermentation of various bacteric species such as Aerobacter Flavobacterium Alcaligenes Micrococcus Bordetella Proteus 15 Cellulomonas Pseudomonas Corynebacterium Salmonella Erwinia Sarcina Escherichia Zanthomonas B-megaterium B.subtilis 20 Achromobacter Also enzymatic preparations obtained by extraction of animal organs, such as pig-kidney acylasis are able to cause hydrolysis of the amidic bond between the carbonyl group of an organic acid and the aminic group of Laspartyi-L-phenylaianine methyl ester.
The enzymes may be added to an aqueous. solution of from 0.2 to 260 g/l of the N-acyl derivative, suitably mildly buffered at different pH according to the enzyme used, that is in a range of from 2 to 9, preferably from 5 to 7. The reaction may be carried out at a temperature of from 10' to 600C, preferably 15' to 400C, for 1 to 48 hours operating in batch or column according to the quantity of the enzyme present in the reaction mixture and to the ratio between the quantity of the enzyme in solution or in the 30 immobilized form and the quantity of N-substituted dipeptide present in the reaction mixture. The yields of the reactions carried out under optimal conditions reach values higher than 80%. The extraction of the product may be carried out using known techniques, but complicated and expensive processes for recovering the unreacted compounds or the undesired by-products may be avoided.
The following Examples and Preparation illustrate the invention.
Other N-acyl derivatives, the preparation of which is not specifically indicated, were obtained in high yields by operating as described in the preparation A, B, C and D and using a suitable acylating derivative as starting material.
Preparation A N-Phenylacetyl-L-up-aspartyl 1 phenylalanine methyl ester 66.6 g of L-aspartic acid were suspended in 100 ml of water. 200 mi of 10% sodium hydroxide were added and the mixture was cooled to W- 17'C. A mixture of 100 mi of 10% sodium hydroxide and 70 mi of phenylacetyl chloride was dropped therein for 1 hour. The mixture was kept for 3 hours at 2WC and then 37% hydrochloric acid was added until the pH was 2. After cooling to 0' -5'C and filtration, the reac- 45 tion mixture was dried to obtain N-phenylacetyl-aspartic acid (120 g), 99. 7% titre.
78 g thereof were suspended in 80 m] of acetic anhydride. The mixture was heated to 800 for 2 hours.
g of N-phenylacetyl-aspartic anhydride were obtained after cooling and precipitation with a solvent.
52 g of N-phenylacetyl-aspartic anhydride were suspended in 52 mi of glacial acetic acid and 100 m[ of dichloroethane, and the suspension was cooled to 100C. 200 m] of dichloroethane containing 40.2 9 of 50 phenylalanine methyl ester was added. 85 g of the title compound we. re obtained after extractions with basis adjusting the pH to acid value and filtration.
PreparationB 55 N-Phenoxyacetyl-L-(xasparty.'-L-phenylalanine methyl ester Operating as described in Preparation A, but using 77.2 g of phenoxyacetyl chloride instead of the phenylacetyl chloride, 110 g ol the title compound were obtained.
Preparation C 60 N-p-hydroxyphenylaceL.yl-L-otp-aspartyl-L-phenylalanine methyl ester Operating as described in Preparation A, but using 60.4 9 of p- hydroxyphenylacetyl chloride instead of the phenylacetyl chloride, 70.7 g of the title compound were obtained.
GB 2 160 870 A 3 Preparation D N-propionyl-L-u.p-aspartyl-L-phenylalanine methyl ester Operating as described in Preparation A, but using 41.8 g of propionyl chloride instead of the phenylacetyl chloride, 33.8 g of the title compound were obtained. The acylasis enzyme compounds were pre5 pared by fermentation with abovementioned microorganisms in specific culture broths.
Preparation E Acylasis enzyme from E. Coli A TCC 11105 The microorganism was fermented in a culture broth consisting of yeast extract, sodium glutammate, phenyl-acetic acid and ammonium salts, buffered so as to have an initial pH of 6.8-6.9. The optimal growth was reached in 10-12 hours with cellulasis dried weight of 300-400 mg/1 00 mi of broth. When the fermentation was over, the cells were separated by centrifugation, washed and passed on to a lysis treatment with n-butyl acetate. The lysate compound was flocculated, clarified and ultrafiltered. The concentrate obtained by selective ultrafiltration was salted with ammonium sulphate. The salted compound consisted of a stable acylasis having an activity of 600-900 Ulmi.
EXAMPLE 1
2 g of N-phenylacetyi-L-aspartyi-L-phenylaianine methyl ester (obtained as described in Preparation A) was dissolved in 100 mi of water with progressive additions of 10% sodium hydroxide, keeping the mix ture under shaking at 370C and at a pH lower than 7.5. When the solution was over, 1 N sodium hydrox- 20 ide or 1 N hydrochloric acid was added to stabilize the pH at 6.5-6 and the mixture was added with 0.5 g of the enzyme compound having an acylasic activity of 50 Ulg, obtained by immobilization of the com pound of Preparation E on a solid substrate, by selective adsorption and cross-linkage with glutaralde hyde, in the presence of albumin.
The mixture was allowed to react for 23 hours at 37'C under shaking, the pH being kept at 6.t0.5 by 25 addition of 1 N sodium hydroxide. At the end of the reaction the immobilized enzyme was separated off by filtration in vacuo through a glass filter and washed with 100 mi of water. The filtrate and the washing liquors were combined and the solution was analysed by high pressure liquid chromatography (HPLC) indicating a hydrolysis yield of N-phenylacetyl- L-a-aspartyi-L- phenylaianine methyl ester of 90% of the theoretic value only 5% of the non-reacted compound and 5% of undesired products. The obtained as- 30 partame was then extracted and crystallized according to suitable preparation processes from low salt containing aqueous solutions, and the free phenylacetic acid was recovered by extraction with solvents or adsorption on resins and used again for further preparations.
EXAMPLE2
2g of N-phenoxyacetyl-L-aspartyl-L-phenylalanine methyl ester (obtained as described in Preparation B) was dissolved in 100 ml of water at 35'C with addition of 10% sodium hydroxide to keep the pH not higher than 7.5. After dissolution the pH was adjusted to 6.0 and 0.5 g of Novozym acylasis 217 at 60 U/g were added, the enzyme being immobilized on a suitable insoluble substrate. The mixture was allowed to react for 24 hours at 35'C under shaking maintaining the pH at 6:LO.5 with addition of 1 N sodium hydroxide, The immobilized enzyme was then recovered by filtration through a glass filter and washed with 10 ml of water. The filtrate and the washing liquors were combined and the solution was chromatographed (HPLC) obtaining a yield of 93% of the theoretic value.
EXAMPLE 3
The reaction was carried out as described in Example 1, except that the enzyme was adsorbed on an ion exchange resin and insolubilised by crosslinkage in the presence of gluteraidehyde and a diamine according to known methods [Hayes R., Biochem. Biophys. Res. Commun 36, 235 (1969)]. The compound having 16 U/g was used in a quantity of 2 g per 100 ml of 2% solution of N-phenylacetyl-L-aspartyl-L- phenylalanine methyl ester. Reaction yields were 80% after 22 hours of reaction.
EXAMPLE 4
The reaction was carried out as described in Example 1, except that the enzyme was insolubilized by grafting onto cellulose acetate fibres according to known processes [Dinelli D., Process Biochem 718,9, (1972)1. The compound had 10.000 Ulg and 1 g of fibre was used to obtain 90% transformation under the 55 conditions of Example 1.
EXAMPLE 4 Bis
The reaction was carried out as described in Example 1, except that the enzyme was insolubilized on porous glass particles with primary aminic functions by activation with gluteraldehyde and a covalent 60 bond of the enzyme on the carbonylic intermediate. The compound had 25 U/g and 2 g of the immobi lized enzyme was used to obtain 75% transformation under the conditions of Example 1.
4 GB 2 160 870 A EXAMPLE 5
The reaction was carried out as described in Example 1, except that the enzyme of preparation E was used in the soluble form. 160 U of enzyme extracted from culture broths of E. Coli was added to 100 m[ of a 2% solution of N-phenylacetyi-L-asparty]-L-phenylalanine methyl ester. The reaction mixture was maintained for 8 hours at 37'C and pH 6-6.5. The yield of the desired product was 87% of the theoretic value.
4 EXAMPLE 6
3 g of N-p-hldroxyphenylacetyl-L-aspartyl-L-phenylalanine methyl ester (obtained as described in Prep- aration Q were dissolved in 100 ml of water, the pH was adjusted to 6 and the solution was heated to 10 40'C. 1 g of acylasis (penicillinacylasis) from E. Coli adsorbed on an ion exchange resin and having the activity of 40 UIg was then added. The reaction mixture was kept under shaking, at 400C, a pH 5.5-6.5 for 20 hours. The immobilized enzyme was then separated off by filtration. The reaction mixture analyzed by the HPLC showed an 82% conversion of the starting material to aspartame.
EXAMPLE 7
Example 6 was repeated except that the enzyme was obtained by extraction of the culture broth of Nocardia and was used in the soluble form. By carrying out the reaction under the described conditions, N-phydroxyphenylacecyl-L-aspartyl-L-phenylaianine methyl ester was transformed into aspartame with a yield of 50% of the theoretic value.
EXAMPLE 8
Example 1 was repeated except that the immobilized enzyme was obtained by extraction from a culture broth oi Proteus, had an activity of 25 Ulg, and was used in a quantity of 1 91100 mi of the reaction mixture. The aspartame yield obtained under these conditions was 48% of the theoretic value.
is EXAMPLE 9
3 g of N-propionyl-L-aspartyl-L-phenylalanine methyl ester obtained according to Preparation D were dissolved in 100 ml of water. The solution was heated to 37'C and the pH was adjusted to 6.5. To the reaction mixture was added 300 U/g of the enzymatic compound obtained by extraction and purification 30 according to known methods of the culture broth of E. Coli. The reaction mixture was kept under shaking for 24 hours at the indicated temperature, keeping the pH at 6.5 0.5. The final yield of aspartame was higher than 40% of the theoretic value.
EXAMPLE 70
Operating as described in Example 9, but substituting a 0.5 g/l solution of N-undecylearbonyl-L-aspartyl-L-phenylalanine methyl ester for the Npropionyl derivative and keeping the pH at 6 1, gave a 30% yield of aspartame.
EXAMPLE 11
2 g of N-formyi-L-aspartyl-L-phenylaianine methyl ester were dissolved in 100 mI of water at 370C. When solution was complete, the pH was adjusted to 6.5-7 with 10% sodium hydroxide and 250 U of an enzymatic compound having acylasic activity obtained from Pseudomonas culture was added. The reaction mixture vjas allowed to stand for 36 hours at 370C. The pH was then adjusted to 4-4.5 and the corn- pound was separated by concentration. The yield of L-ct-aspartyl-L- phenylalanine methyl ester was 20% 45 of the theoretic value.
EXAMPLE 12
Operating as in Example 2, except that an enzyme extracted from broth culture of Aspergillus and hav % ing 18.000 W9 was used at a concentration of 2% of that of N-phenoxy- methyi-L-aspartame, with hydrol- 50 ysis yield of 20% of the theoretic value.
EXAMPLE 13
As described in Example 1, except for the enzyme was not isolated, but the cells are immobilized "in toto": 1 g of humid cells obtgined from E. Coli culture was suspended in 5 mi of buffer phosphate 50 5E mM, pH 7.5. The solution was added with 0.5% of bovine albumin and 1% of glutaraldehyde. After 2 hours at room temperature the obtained pellets were separated by filtration and washed with buffer phosphate 50 mM. The compound used had an activity of 14 Ulg and was used in a quantity of 2 g per mi of a 20,6 solution of 1,1 -phenylacety]-L-aspa rtyl- L-phenylalanine methyl ester. The transformation yields after 8 hours of incubation at 37'C were 65% of the theoretic value.
EXAMPLE 141
As described in Example 2, except for the enzyme was not isolated and the mycelium mass obtained from a Streptomyces culture was immobilized. The linkage process was analogous to that described in Example 13. The cross-iinked mycelium mass was separated by filtration, washed with water and lyophi- 61 GB 2 160 870 A 5 lized. The Iyophilized compound was roughly triturated and used for the selective hydrolysis of N-phenoxyacetyi-L-aspartyi-L-phenylaianine methyl ester. 2 g of the compound having an activity of 12 U/g was used per 100 mi of 2% solution of the product to be hydrolysed. The transformation yields after 8 hours of incubation at 37'C are 60% of the theoretic value.
EXAMPLE 15
1 g of N-propo)cyacetyl-L-aspartyl-L-phenylaianine methyl ester was dissolved in 100 ml of water at 37'C, adjusting the pH to 6 with 10% sodium hydroxide. To the reaction mixture was added 250 U of the enzymatic compound having acylasic activity obtained from Cephalosporium culture. The mixture was allowed to stand for 20 hours at 37oC. At the end of the enzymatic reaction the yield was 45% of the theoretic value.
EXAMPLE 16 1 g of N-tolylo)cyacetyl-L-aspartyl-L-phenylalanine methyl ester was dissolved in 100 ml of water. 10% sodium hydroxide was added progressively to pH 6-7. To the mixture was added 250 U of enzymatic compound having acylasic activity obtained from Actinoplanes Utahensis cultures. The reaction was carried out at 37'C for 24 hours. The hydrolysis yield of the N-tolyloxyacetyl derivative was 40% of the theoretic value.
Claims (15)
1. A process for the preparation of an ester of L-ct-aspartyi- Lphenylalanine having the general formula 1 COOR, 1 H,N-CH-CO-NH-CH-CH2-C,H, 1 C1-12-COOH (1) wherein R, represents an alkyl group having from 1 to 4 carbon atoms, the process comprising enzymatically hydrolyzing an N-acyl derivative of the desired product, which N-acyl derivative has the general formula 11 COOP, i R-CO-NI-I-CH-CO-NH-CH-CH2-C^ 1 H2COOH wherein R represents a free or substituted alkyl, alkenyl or phenylalkyl group having from 1 to 11 carbon atoms and R, is as above defined.
2. A process according to claim 1 in which R, represents a methyl group.
3. A process according to claim 1 or claim 2 in which R represents a hydrogen atom or a group of the formula -CH3, -(CH.),CH, wherein n is a number of from 1 to 10, -C,H,, - CH2-C,H,, - CH2-C,H,-OH, -CH2-C,H.N021 -C,H,(OCH3)2, -CH2-C,H,(OH)2, -CH2-CH=CH-CH,-CH,-CH,-S-CH,-CH=CH2 or -CH2-0-R' wherein R' repre sents a phenyl, hydroxyphenyl or tolyl group or a straight chain alkyl group having from 1 to 6 carbon atoms.
4. A process according to any preceding claim in which the enzymatic hydrolysis is carried out using a hydrolasic enzyme.
5. A process according to claim 4 in which the hydrolasic enzyme is prepared from a microorganism.
6. A process according to claim 5 in which the microorganism is an actinomycete, fungus or bacterium.
7. A process according to claim 6 in whi.;h the actinomycete is of the Nocardia, Actinoplanes or Streptomyces genus.
8. A process according to claim 6 in which the fungus is of the Alternatia, Aspergillus, Botrytis, Cephalosporium, Cryptococcus, Emericellopsis, Epicoccum, Epidermophyton, Fusarium, Mucor, Penicillium, Phoma, Tritoderma, T richophyton or Trichosphoron genus.
9. A process according to claim 6 in which the bacterium is of the Aerobacter, Alcaligenes, Bordetella, Cellulomonas, Corynebacterium, Erwinia, Escherichia Achromobacter, Flavobacterium, Micrococcus, Proteus, Pseudomonas, Salmonella, Sarcina, Eanthomonas or B. subtilis genus.
10. A process according to any preceding claim in which the enzymatic hydrolysis is carried out either in the presence of microbic cells producing the desired enzyme or in the presence of a separately prepared enzyme.
6 GB 2 160 870 A 6
11. A process according to claim 10 in which the enzymatic hydrolysis is carried out in the presence of an enzyme prepared separately, isolated and purified.
12. A process according to claim 10 or claim 11 in which the enzyme or the microbic cells producing it are either immobilized on an inert substrate or insolubilized by a cross-linkage process.
13. A process according to any preceding claim in which the enzymatic hydrolysis is carried out in aqueous solution at a concentration of from 0.2 to 260 g/l, buffered at a pH of from 2 to 9, at a temperature of from 10' to 60T.
14. A process according to claim 13 in which the aqueous solution is buffered at a pH of from 5 to 7.
15. A process according to claim 13 or claim 14 in which the enzymatic hydrolysis is carried out at a 10 temperature of from 15 to 40T.
Printed in the UK for HMSO, D8818935, l 1185, 7102. Published by The Patent Office, 25 Southampton Buildings, London, WC2A lAY, from which copies may be obtained.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21622/84A IT1176332B (en) | 1984-06-27 | 1984-06-27 | PROCEDURE FOR THE PREPARATION OF PEPTIDES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8516281D0 GB8516281D0 (en) | 1985-07-31 |
| GB2160870A true GB2160870A (en) | 1986-01-02 |
| GB2160870B GB2160870B (en) | 1987-07-22 |
Family
ID=11184455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08516281A Expired GB2160870B (en) | 1984-06-27 | 1985-06-27 | Process for preparing peptides |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4668625A (en) |
| JP (1) | JPH0669389B2 (en) |
| BE (1) | BE902474A (en) |
| DE (1) | DE3523018A1 (en) |
| FR (1) | FR2566800B1 (en) |
| GB (1) | GB2160870B (en) |
| IT (1) | IT1176332B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0214550A3 (en) * | 1985-09-09 | 1988-08-10 | Hoechst Aktiengesellschaft | Process for the preparation of aspartame and agent for its preparation |
| US4935355A (en) * | 1986-04-15 | 1990-06-19 | Synthetech, Inc. | Preparation of dipeptides |
| EP0557954A3 (en) * | 1992-02-26 | 1994-10-26 | Chisso Corp | A process for producing epsilon-poly-l-lysine |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2589480B1 (en) * | 1985-11-05 | 1988-09-16 | Hoechst France | BIOLOGICAL PROCESS FOR THE PREPARATION OF METHYL N-(N-BENZYLOXYCARBONYL L-ASPARTYL-1) L-PHENYLALANINATE |
| US5214145A (en) * | 1988-08-31 | 1993-05-25 | Eastman Kodak Company | Trisubstituted piperazin-2,5-diones |
| US4992552A (en) * | 1988-08-31 | 1991-02-12 | Eastman Kodak Company | Process for preparation of amino acids |
| US5144073A (en) * | 1988-08-31 | 1992-09-01 | Hubbs John C | Process for preparation of dipeptides |
| US5252464A (en) * | 1989-03-14 | 1993-10-12 | Carlsberg Biotechnology Ltd. A/S | Process for producing pentapeptides and intermediates for use in the synthesis |
| EP1013663A1 (en) * | 1998-12-22 | 2000-06-28 | Holland Sweetener Company V.O.F. | Synthesis and recovery of aspartame involving enzymatic deformylation step |
| WO2000037486A1 (en) * | 1998-12-22 | 2000-06-29 | Holland Sweetener Company V.O.F. | Synthesis and recovery of aspartame involving enzymatic deformylation step |
| US6617127B2 (en) * | 1998-12-22 | 2003-09-09 | Holland Sweetener Company, V.O.F. | Synthesis and recovery of aspartame involving enzymatic deformylation step |
| US6458538B1 (en) * | 1999-12-14 | 2002-10-01 | Ptc Therapeutics, Inc. | Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay |
| AU2003247610A1 (en) * | 2002-06-21 | 2004-01-06 | Ptc Therapeutics, Inc. | METHODS FOR IDENTIFYING SMALL MOLECULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY |
| WO2004010106A2 (en) * | 2002-07-24 | 2004-01-29 | Ptc Therapeutics, Inc. | METHODS FOR IDENTIFYING SMALL MOLEDULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY |
| BR112015015075A2 (en) | 2012-12-24 | 2019-01-15 | Univ Ramot | agents for treating genetic diseases resulting from meaningless mutations and methods for identifying them. |
| CN106146378B (en) * | 2015-03-23 | 2018-09-18 | 兰州大学 | A kind of acylated homoserine lactone class compound and its environmentally friendly application |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH590292A5 (en) * | 1973-12-20 | 1977-07-29 | Ciba Geigy Ag | |
| US4264734A (en) * | 1977-02-11 | 1981-04-28 | Merck & Co., Inc. | Process for producing antibiotic desacetyl 890A10 |
| US4315074A (en) * | 1978-05-19 | 1982-02-09 | Pierce Chemical Company | Molecular transformation procedure |
| US4302540A (en) * | 1979-10-25 | 1981-11-24 | Kyowa Hakko Kogyo Co., Ltd. | Process of producing optically active cephalosporin analogs by enzyme selective deacylation |
| US4293648A (en) * | 1979-12-12 | 1981-10-06 | G. D. Searle & Co. | Process for esterification of α-L-aspartyl-L-phenylalanine |
| US4360593A (en) * | 1981-04-03 | 1982-11-23 | Bristol-Myers Company | Process of producing a peptide antibiotic with Bacillus circulans |
| DE3479214D1 (en) * | 1983-04-28 | 1989-09-07 | Ajinomoto Kk | Process for the production of l-aspartyl-l-phenylalanine methyl ester or l-aspartyl-l-phenylalanine |
-
1984
- 1984-06-27 IT IT21622/84A patent/IT1176332B/en active
- 1984-08-07 US US06/638,494 patent/US4668625A/en not_active Expired - Fee Related
-
1985
- 1985-05-20 FR FR8507551A patent/FR2566800B1/en not_active Expired
- 1985-05-22 BE BE0/215050A patent/BE902474A/en not_active IP Right Cessation
- 1985-06-26 JP JP60138078A patent/JPH0669389B2/en not_active Expired - Lifetime
- 1985-06-27 GB GB08516281A patent/GB2160870B/en not_active Expired
- 1985-06-27 DE DE19853523018 patent/DE3523018A1/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0214550A3 (en) * | 1985-09-09 | 1988-08-10 | Hoechst Aktiengesellschaft | Process for the preparation of aspartame and agent for its preparation |
| US4935355A (en) * | 1986-04-15 | 1990-06-19 | Synthetech, Inc. | Preparation of dipeptides |
| EP0557954A3 (en) * | 1992-02-26 | 1994-10-26 | Chisso Corp | A process for producing epsilon-poly-l-lysine |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2160870B (en) | 1987-07-22 |
| JPH0669389B2 (en) | 1994-09-07 |
| JPS6121095A (en) | 1986-01-29 |
| GB8516281D0 (en) | 1985-07-31 |
| FR2566800A1 (en) | 1986-01-03 |
| BE902474A (en) | 1985-09-16 |
| US4668625A (en) | 1987-05-26 |
| IT8421622A1 (en) | 1985-12-27 |
| IT1176332B (en) | 1987-08-18 |
| FR2566800B1 (en) | 1988-12-23 |
| DE3523018A1 (en) | 1986-01-02 |
| IT8421622A0 (en) | 1984-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2160870A (en) | Process for preparing peptides | |
| US5283182A (en) | Preparation of immobilized hydantoinase stabilized with divalent metal ions | |
| FI66021B (en) | ENZYMATISC FOERFARANDE FOER FRAMSTAELLNING AV OPTISKT ACTIVE D-AMINOSYROR UR MOTSVARANDE HYDANTOINER ELLER RASEMISKA CARBAMOYLDERIVAT | |
| US4774179A (en) | Process for preparing a 7-aminocephalosporanic acid compound | |
| US4111749A (en) | Method of converting racemic hydantoins into optically active aminoacids | |
| EP0264457A1 (en) | Process for preparing optically active cyclopropanecarboxylic acids | |
| US4414328A (en) | Process for the preparation of deacetylcephalosporin C | |
| EP0322032A3 (en) | One-step enzymatic conversion of cephalosporin c and derivatives to 7-aminocephalosporanic acid and derivatives | |
| US4981789A (en) | One-step enzymatic conversion of cephalosporin C and derivatives to 7-aminocephalosporanic acid and derivatives | |
| US5166061A (en) | Process for the production of 4-halo-3-hydroxybutyronitrile with Corynebacterium or Microbacterium | |
| US5888804A (en) | Processes for production of optically active quinuclidinol | |
| CA1239609A (en) | Optically active substituted butyramide, and process for the optical separation of substituted butyramide | |
| JPS589680B2 (en) | Amino Kagou Butsuno Seihou | |
| EP0152977B1 (en) | Process for the preparation of l-alpha-aminoacids | |
| US4492757A (en) | Process for preparing L-threonine | |
| EP0261836B1 (en) | Immobilised enzyme preparation and its use | |
| US6869788B2 (en) | DNA encoding novel D-aminoacylase and process for producing D-amino acid by using the same | |
| AU684122B2 (en) | Enzymatic acylation of 3-hydroxymethly cephalosporins | |
| HK1003230B (en) | Immobilised enzyme preparation and its use | |
| US5723321A (en) | Process for preparing D-lysine | |
| CA1160584A (en) | Cephalosporin analogs | |
| JP2712331B2 (en) | Acylamino acid racemase, its production and use | |
| KR910007849B1 (en) | New microorganism stretomyces spy-183 | |
| JPS6319158B2 (en) | ||
| JPH07274985A (en) | Process for producing D-γ-methylleucine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940627 |